Alex Leech
InvestorPartner, Biovelocita Strategy at Sofinnova Partners
London, England, United Kingdom
Find your path to Alex
304 people in our graph share verified history with Alex — schools, employers, funds. One of them is your warm intro.
John HortonunlockedAlex: together at Henley Business School (2003)
×3Alex: together at Henley Business School
×2Alex: together at SV Health Investors
×6Alex: together at University of Sussex
About
Alex Leech is a Partner at Sofinnova Partners and CEO of Forth Therapeutics. He has founded biotechnology companies and has experience in fundraising and mergers and acquisitions.
Experience
- Forth TherapeuticsCEOcurrent2024 — present
- Sofinnova PartnersPartnercurrent2023 — presentLondon, United Kingdom
- Sevenless TherapeuticsChaircurrent2020 — presentGreater London, England, United Kingdom
- Ensocell Therapeutics LtdChair2023 — 2026Cambridge, England, United Kingdom
- Bicycle TherapeuticsEIR2021 — 2023Cambridge, England, United Kingdom
- 2N PharmaChair2021 — 2023Denmark
- SV Health InvestorsVenture Partner2019 — 2021London Area, United Kingdom
- AlchemabCEO2019 — 2021Cambridge, England, United Kingdom
- Zarodex TherapeuticsCEO2017 — 2020London, United Kingdom
- Camphos TherapeuticsCEO2017 — 2019Cambridge
- Creabilis SACEO2015 — 2017UK / Italy / Luxembourg
- Creabilis SAChief Operating Officer2010 — 2015UK / Italy / Luxembourg
- Solace Pharmaceuticals Inc.Executive Director, Head of Operations2007 — 2010Cambridge, MA & UK
- PfizerProject Management Group Head2003 — 2007Global R&D
Skills & more
Biotechnology6Strategy2Operations Management1Corporate Finance1Pharmaceutical Industry13Project Management3Clinical Research1Clinical Development4LifesciencesClinical Trials6R&D1New Business Development
+6 more
Product DevelopmentOutsourcingAutomotiveEngineeringLean ManufacturingSix SigmaFrom Alex's professional profile.
Colleagues at Sofinnova Partners
Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andy Weiss
Operating Advisor at Sonder Capital
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners
Anna Belousova
Associate, Industrial Biotech Strategy at Sofinnova Partners
Frequently asked questions
- Who is Alex Leech?
- Alex Leech is a Partner at Sofinnova Partners and CEO of Forth Therapeutics. He has founded biotechnology companies and has experience in fundraising and mergers and acquisitions.
- Where does Alex Leech work?
- Alex Leech is Partner, Biovelocita Strategy at Sofinnova Partners.
- Where did Alex Leech go to school?
- Alex Leech studied at Henley Business School (M.B.A, Business); University of Sussex (BEng, Mechanical Engineering).
Same school
Also attended Henley Business School62
John HortonInvestor at DN CapitalIrene ArdenstedtInvestor at Luminar VenturesCharles VasletSenior Partner, Chief Revenue Officer at Emerald Technology Ventures AgSanne van ErpInvestment manager at NoaberKieran MudryyPartner at 4BIO CapitalJames ChapmanEntrepreneur in Residence at Cambridge Innovation Capital
+ 56 more
Also attended University of Sussex90
Hamish GarnettAssociate at Manta Ray VenturesMolly CookeTeam Assistant at NorthzoneJackson HeddyCFO at NorthzoneGeorgia AbbottAssociate Director at Marlin Equity PartnersSimon SegarsExecutive Advisor at Black Opal VenturesYuki KanematsuOperations Manager at Sozo Ventures
+ 84 more
Shared employers
Also worked at Bicycle Therapeutics5
Also worked at Alchemab4
Also worked at Pfizer229
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 223 more